S Deadeye (Ranger) Fast mapping, farming Map tempo is king in 0.4, and Deadeye’s kit naturally plays that game. S Pathfinder (Ranger) Flexible routing, scaling Alternative routing plus jewel value ...

This tier list is based on accessibility for new players—how forgiving the class feels early, how smoothly it levels, and how much it reduces trial-and-error while ...

Eli Lilly hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs. The company also released long-awaited ...

Good day, and welcome to the Equity Residential 2Q 2025 Earnings Conference Call and Webcast. Today's conference is being recorded. At this time, I'd like to turn the conference over to Mr. Marty ...

As competition in the key business sector ramps up, Virgin Media O2 (VMO2) has revealed that it has seen falls in revenues in its fixed broadband business over the course of the second quarter of 2025 ...

Chubb Limited ended the second quarter of 2025 with net income of $2.97 billion, or $7.35 per share, up 33.1% from the same period last year. The company also posted a record $2.48 billion in core ...

Retail sales growth in June slowed to 4.8% from a year earlier, compared with the 6.4% increase in May. Industrial output beat estimates, expanding by 6.8% from a year earlier. Fixed asset investment ...

China's Q2 GDP grows 5.2% vs Q1's 5.4%, above the 5.1% forecast June data show weaker retail sales, stronger factory output Consumers, businesses face uncertainty amid US tariff risks Property ...

China reported better-than-expected economic growth for the second quarter in the face of an ongoing trade war with the United States, as diversification efforts to non-US markets buoyed exports.

July 15 (Reuters) - China's economy grew at a slightly faster pace than expected in the second quarter, showing resilience in the face of U.S. tariffs, though analysts warn of intensifying headwinds ...

Exercise may significantly reduce the risk of colon cancer returning in patients after treatment, a new study has found. The late-phase trial, published Sunday in the New England Journal of Medicine ...